{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:15:59Z","timestamp":1793495759893,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI120997"],"award-info":[{"award-number":["R01 AI120997"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune responses against neuraminidase (NA) and hemagglutinin (HA) are critical for developing effective influenza vaccines, yet their role in influenza transmission remains unclear. We conducted household transmission studies in Managua, Nicaragua, to assess the impact of anti-NA and anti-HA antibodies induced by natural infection on influenza A\/H3N2 susceptibility and infectivity. Using mathematical models capturing household transmission dynamics, we found that high pre-existing antibody levels against the HA head (&gt;31, [95% CrI 13\u201367]), HA stalk (&gt;35, [95% CrI 11\u201366]), and NA (&gt;31, [95% CrI 12\u201368]) are associated with reduced susceptibility to infection (relative susceptibility: HA head, 0.63 [95% CrI 0.42\u20130.98]; HA stalk, 0.66 [95% CrI 0.44\u20130.99]; NA, 0.49 [95% CrI 0.30\u20130.76]). HA stalk (&gt;58 [95% CrI: 47\u201370]) and NA (&gt;27 [95% CrI: 15\u201343]) are associated with reduced infectivity (relative infectivity: NA, 0.55 [95% CrI: 0.32\u20130.98], HA stalk 0.53 [95% CrI: 0.27\u20130.97]). These findings suggest that influenza vaccines designed to elicit NA immunity in addition to HA immunity may not only enhance protection against infection but also reduce onward transmission.<\/jats:p>","DOI":"10.1038\/s41467-025-65283-0","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:02:57Z","timestamp":1765447377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A\/H3N2 virus"],"prefix":"10.1038","volume":"16","author":[{"given":"Gregory","family":"Hoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-0801","authenticated-orcid":false,"given":"Hannah E.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nery","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Plazaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Shotwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Balmaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-4549","authenticated-orcid":false,"given":"Simon","family":"Cauchemez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-7877","authenticated-orcid":false,"given":"Aubree","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"65283_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","volume":"16","author":"EA Belongia","year":"2016","unstructured":"Belongia, E. A. et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect. Dis. 16, 942\u2013951 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"65283_CR2","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","volume":"34","author":"F Berlanda Scorza","year":"2016","unstructured":"Berlanda Scorza, F., Tsvetnitsky, V. & Donnelly, J. J. Universal influenza vaccines: shifting to better vaccines. Vaccine 34, 2926\u20132933 (2016).","journal-title":"Vaccine"},{"key":"65283_CR3","first-page":"3273","volume":"118","author":"PC Doherty","year":"2008","unstructured":"Doherty, P. C. & Kelso, A. Toward a broadly protective influenza vaccine. J. Clin. Invest. 118, 3273\u20133275 (2008).","journal-title":"J. Clin. Invest."},{"key":"65283_CR4","doi-asserted-by":"crossref","unstructured":"Krammer, F. et al. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines? MBio 9, e02332-17 (2018).","DOI":"10.1128\/mBio.02332-17"},{"key":"65283_CR5","doi-asserted-by":"crossref","unstructured":"Nachbagauer, R. et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. NPJ Vaccines 2, eCollection (2017).","DOI":"10.1038\/s41541-017-0026-4"},{"key":"65283_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","volume":"47","author":"CI Paules","year":"2017","unstructured":"Paules, C. I., Marston, H. D., Eisinger, R. W., Baltimore, D. & Fauci, A. S. The pathway to a universal influenza vaccine. Immunity 47, 599\u2013603 (2017).","journal-title":"Immunity"},{"key":"65283_CR7","doi-asserted-by":"publisher","first-page":"D17","DOI":"10.1016\/j.vaccine.2008.07.048","volume":"26","author":"KL Nichol","year":"2008","unstructured":"Nichol, K. L. Efficacy and effectiveness of influenza vaccination. Vaccine 26, D17\u2013D22 (2008).","journal-title":"Vaccine"},{"key":"65283_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002149","volume":"3","author":"C Jackson","year":"2013","unstructured":"Jackson, C., Vynnycky, E., Hawker, J., Olowokure, B. & Mangtani, P. School closures and influenza: systematic review of epidemiological studies. BMJ Open 3, e002149 (2013).","journal-title":"BMJ Open"},{"key":"65283_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.vaccine.2005.09.017","volume":"24","author":"R Jordan","year":"2006","unstructured":"Jordan, R. et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 24, 1047\u20131062 (2006).","journal-title":"Vaccine"},{"key":"65283_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","volume":"301","author":"M Arnolds","year":"1973","unstructured":"Arnolds, M. & Alanp, K. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 301, 623\u2013625 (1973).","journal-title":"Lancet"},{"key":"65283_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","volume":"212","author":"AS Monto","year":"2015","unstructured":"Monto, A. S. et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J. Infect. Dis. 212, 1191\u20131199 (2015).","journal-title":"J. Infect. Dis."},{"key":"65283_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/vaccines8030409","volume":"8","author":"LT Giurgea","year":"2020","unstructured":"Giurgea, L. T., Morens, D. M., Taubenberger, J. K. & Memoli, M. J. Influenza neuraminidase: A neglected protein and its potential for a better influenza vaccine. Vaccines 8, 409 (2020).","journal-title":"Vaccines"},{"key":"65283_CR13","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/cid\/ciz639","volume":"70","author":"HE Maier","year":"2020","unstructured":"Maier, H. E. et al. Pre-existing antineuraminidase antibodies are associated with shortened duration of influenza A(H1N1)pdm virus shedding and illness in naturally infected adults. Clin. Infect. Dis. 70, 2290\u20132297 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"65283_CR14","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"NM Bouvier","year":"2008","unstructured":"Bouvier, N. M. & Palese, P. The biology of influenza viruses. Vaccine 26, D49\u2013D53 (2008).","journal-title":"Vaccine"},{"key":"65283_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01057-23","volume":"97","author":"M McMahon","year":"2023","unstructured":"McMahon, M. et al. Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner. J. Virol. 97, e0105723 (2023).","journal-title":"J. Virol."},{"key":"65283_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00927-21","volume":"7","author":"J Tan","year":"2022","unstructured":"Tan, J. et al. Murine broadly reactive antineuraminidase monoclonal antibodies protect mice from recent influenza B virus isolates and partially inhibit virus transmission in the guinea pig model. mSphere 7, e0092721 (2022).","journal-title":"mSphere"},{"key":"65283_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01421-21","volume":"96","author":"J Tan","year":"2022","unstructured":"Tan, J. et al. Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model. J. Virol. 96, e0142121 (2022).","journal-title":"J. Virol."},{"key":"65283_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1297-9716-42-120","volume":"42","author":"A Romagosa","year":"2011","unstructured":"Romagosa, A. et al. Vaccination of influenza a virus decreases transmission rates in pigs. Vet. Res. 42, 120 (2011).","journal-title":"Vet. Res."},{"key":"65283_CR19","doi-asserted-by":"crossref","unstructured":"McMahon, M. et al. Mucosal immunity against neuraminidase prevents influenza B virus transmission in guinea pigs. MBio 10, e00560-19 (2019).","DOI":"10.1128\/mBio.00560-19"},{"key":"65283_CR20","doi-asserted-by":"crossref","unstructured":"Singanayagam, A., Zambon, M. & Barclay, W. S. Influenza virus with increased pH of hemagglutinin activation has improved replication in cell culture but at the cost of infectivity in human airway epithelium. J. Virol. 93, e00058-19 (2019).","DOI":"10.1128\/JVI.00058-19"},{"key":"65283_CR21","first-page":"339","volume":"75","author":"P Fazel","year":"2020","unstructured":"Fazel, P., Mehrabanpour, M. J. & Shahkarami, M. K. Phylogenetic analysis of hemagglutinin gene and evaluation of the viral shedding of H9N2 avian influenza viruses using real-time RT-PCR in SPF chickens. Arch. Razi Inst. 75, 339\u2013348 (2020).","journal-title":"Arch. Razi Inst."},{"key":"65283_CR22","doi-asserted-by":"crossref","unstructured":"Park, J.-K. et al. Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A\/H1N1pdm virus. MBio 9, e02284-17 (2018).","DOI":"10.1128\/mBio.02284-17"},{"key":"65283_CR23","doi-asserted-by":"publisher","first-page":"e0154418","DOI":"10.1371\/journal.pone.0154418","volume":"11","author":"TK Tsang","year":"2016","unstructured":"Tsang, T. K. et al. Individual correlates of infectivity of influenza A virus infections in households. PLoS ONE 11, e0154418 (2016).","journal-title":"PLoS ONE"},{"key":"65283_CR24","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1002\/sim.1912","volume":"23","author":"S Cauchemez","year":"2004","unstructured":"Cauchemez, S., Carrat, F., Viboud, C., Valleron, A. J. & Bo\u00eblle, P. Y. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat. Med. 23, 3469\u20133487 (2004).","journal-title":"Stat. Med."},{"key":"65283_CR25","unstructured":"Centers for Disease Control and Prevention Real-time RT-PCR (rRT-PCR) Protocol for Detection and Characterization of Influenza (Centers for Disease Control and Prevention, 2025)."},{"key":"65283_CR26","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"65283_CR27","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1128\/JVI.02289-14","volume":"88","author":"GS Tan","year":"2014","unstructured":"Tan, G. S. et al. Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin. J. Virol. 88, 13580\u201313592 (2014).","journal-title":"J. Virol."},{"key":"65283_CR28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/infdis\/jiae258","volume":"230","author":"G Hoy","year":"2024","unstructured":"Hoy, G. et al. Humoral correlates of protection against influenza A\/H3N2 virus infection. J. Infect. Dis. 230, 1319\u20131328 (2024).","journal-title":"J. Infect. Dis."},{"key":"65283_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1017\/S0022172400022610","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. Epidemiol. Infect. 70, 767\u2013777 (1972).","journal-title":"Epidemiol. Infect."},{"key":"65283_CR30","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962\u2013967 (2019).","journal-title":"Nat. Med."},{"key":"65283_CR31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/infdis\/jiv225","volume":"212","author":"TK Tsang","year":"2015","unstructured":"Tsang, T. K. et al. Influenza A virus shedding and infectivity in households. J. Infect. Dis. 212, 1420\u20131428 (2015).","journal-title":"J. Infect. Dis."},{"key":"65283_CR32","doi-asserted-by":"publisher","first-page":"a038430","DOI":"10.1101\/cshperspect.a038430","volume":"11","author":"J Nayak","year":"2021","unstructured":"Nayak, J., Hoy, G. & Gordon, A. Influenza in children. Cold Spring Harb. Perspect. Med. 11, a038430 (2021).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"65283_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004310","volume":"10","author":"S Cauchemez","year":"2014","unstructured":"Cauchemez, S. et al. Determinants of influenza transmission in South East Asia: insights from a household cohort study in Vietnam. PLoS Pathog. 10, e1004310 (2014).","journal-title":"PLoS Pathog."},{"key":"65283_CR34","doi-asserted-by":"publisher","first-page":"a038711","DOI":"10.1101\/cshperspect.a038711","volume":"11","author":"RC Mettelman","year":"2021","unstructured":"Mettelman, R. C. & Thomas, P. G. Human susceptibility to influenza infection and severe disease. Cold Spring Harb. Perspect. Med. 11, a038711 (2021).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"65283_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy443","volume":"219","author":"QS Huang","year":"2019","unstructured":"Huang, Q. S. et al. Risk factors and attack rates of seasonal influenza infection: results of the southern hemisphere influenza and vaccine effectiveness research and surveillance (SHIVERS) seroepidemiologic cohort study. J. Infect. Dis. 219, 347\u2013357 (2019).","journal-title":"J. Infect. Dis."},{"key":"65283_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/irv.12383","volume":"10","author":"JP Weir","year":"2016","unstructured":"Weir, J. P. & Gruber, M. F. An overview of the regulation of influenza vaccines in the United States. Influenza Other Respir. Viruses 10, 354\u2013360 (2016).","journal-title":"Influenza Other Respir. Viruses"},{"key":"65283_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.epidem.2013.09.001","volume":"5","author":"AS Azman","year":"2013","unstructured":"Azman, A. S. et al. Household transmission of influenza A and B in a school-based study of non-pharmaceutical interventions. Epidemics 5, 181\u2013186 (2013).","journal-title":"Epidemics"},{"key":"65283_CR38","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3201\/eid2410.161258","volume":"24","author":"A Gordon","year":"2018","unstructured":"Gordon, A. et al. Influenza transmission dynamics in urban households, Managua, Nicaragua, 2012-2014. Emerg. Infect. Dis. 24, 1882\u20131888 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"65283_CR39","unstructured":"World Health Organization. WHO Manual on Animal Influenza Diagnosis and Surveillance (WHO, 2002)."},{"key":"65283_CR40","unstructured":"World Health Organization. WHO Information for the Molecular Detection of Influenza Viruses (WHO, 2020)."},{"key":"65283_CR41","unstructured":"Centers for Disease Control and Prevention Real-time RT-PCR (rRT-PCR) Protocol for Detection and Characterization of Influenza\u2013Influenza A and Influenza B (Centers for Disease Control and Prevention, 2025)."},{"key":"65283_CR42","doi-asserted-by":"publisher","unstructured":"Margine, I., Palese, P. & Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Visual. Exp. https:\/\/doi.org\/10.3791\/51112 (2013).","DOI":"10.3791\/51112"},{"key":"65283_CR43","doi-asserted-by":"publisher","first-page":"e1006041","DOI":"10.1371\/journal.pcbi.1006041","volume":"14","author":"G Viejo","year":"2018","unstructured":"Viejo, G., Cortier, T. & Peyrache, A. Brain-state invariant thalamo-cortical coordination revealed by non-linear encoders. PLoS Comput. Biol. 14, e1006041 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"65283_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/jcss.1997.1504","volume":"55","author":"Y Freund","year":"1997","unstructured":"Freund, Y. & Schapire, R. E. A decision-theoretic generalization of on-line learning and an application to boosting. J. Comput. Syst. Sci. 55, 119\u2013139 (1997).","journal-title":"J. Comput. Syst. Sci."},{"key":"65283_CR45","doi-asserted-by":"crossref","unstructured":"Schapire, R. E. The boosting approach to machine learning: an overview. In Nonlinear Estimation and Classification 149\u2013171 (Springer New York, 2003).","DOI":"10.1007\/978-0-387-21579-2_9"},{"key":"65283_CR46","doi-asserted-by":"publisher","first-page":"e0224365","DOI":"10.1371\/journal.pone.0224365","volume":"14","author":"A Vabalas","year":"2019","unstructured":"Vabalas, A., Gowen, E., Poliakoff, E. & Casson, A. J. Machine learning algorithm validation with a limited sample size. PLoS ONE 14, e0224365 (2019).","journal-title":"PLoS ONE"},{"key":"65283_CR47","unstructured":"Lundberg, S.M. & Su-In Lee. S.I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 30 https:\/\/api.semanticscholar.org\/CorpusID:21889700 (2017)."},{"key":"65283_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/00401706.1995.10484341","volume":"37","author":"M Niknian","year":"1995","unstructured":"Niknian, M. Permutation tests: a practical guide to resampling methods for testing hypotheses. Technometrics 37, 341\u2013342 (1995).","journal-title":"Technometrics"},{"key":"65283_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/aje\/kwm375","volume":"167","author":"F Carrat","year":"2008","unstructured":"Carrat, F. et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167, 775\u2013785 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"65283_CR50","first-page":"RRN1130","volume":"1","author":"A Ghani","year":"2009","unstructured":"Ghani, A. et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Curr. 1, RRN1130 (2009).","journal-title":"PLoS Curr."},{"key":"65283_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tim.2015.10.012","volume":"24","author":"TK Tsang","year":"2016","unstructured":"Tsang, T. K., Lau, L. L. H., Cauchemez, S. & Cowling, B. J. Household transmission of influenza virus. Trends Microbiol. 24, 123\u2013133 (2016).","journal-title":"Trends Microbiol."},{"key":"65283_CR52","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/infdis\/jiu186","volume":"210","author":"TK Tsang","year":"2014","unstructured":"Tsang, T. K. et al. Association between antibody titers and protection against influenza virus infection within households. J. Infect. Dis. 210, 684\u2013692 (2014).","journal-title":"J. Infect. Dis."},{"key":"65283_CR53","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMoa0905498","volume":"361","author":"S Cauchemez","year":"2009","unstructured":"Cauchemez, S. et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N. Engl. J. Med. 361, 2619\u20132627 (2009).","journal-title":"N. Engl. J. Med."},{"key":"65283_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jtbi.2010.12.017","volume":"272","author":"H Nishiura","year":"2011","unstructured":"Nishiura, H. & Inaba, H. Estimation of the incubation period of influenza A (H1N1-2009) among imported cases: addressing censoring using outbreak data at the origin of importation. J. Theor. Biol. 272, 123\u2013130 (2011).","journal-title":"J. Theor. Biol."},{"key":"65283_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-7622-4-2","volume":"4","author":"H Nishiura","year":"2007","unstructured":"Nishiura, H. Early efforts in modeling the incubation period of infectious diseases with an acute course of illness. Emerg. Themes Epidemiol. 4, 2 (2007).","journal-title":"Emerg. Themes Epidemiol."},{"key":"65283_CR56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/aje\/kwv115","volume":"182","author":"V Virlogeux","year":"2015","unstructured":"Virlogeux, V. et al. Estimating the distribution of the incubation periods of human avian influenza A(H7N9) virus infections. Am. J. Epidemiol. 182, 723\u2013729 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"65283_CR57","unstructured":"Betancourt, M. Markov Chain Monte Carlo in Practice (Chapman and Hall\/CRC, 1995)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65283-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:03:03Z","timestamp":1765447383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65283-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65283"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65283-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Icahn School of Medicine at Mount Sinai has filed patent applications related to SARS-CoV-2 serological assays, NDV-based SARS-CoV-2 vaccines, influenza virus vaccines and influenza virus therapeutics, which list Florian Krammer as co-inventor. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2 and another company, CastleVax, to develop SARS-CoV-2 vaccines. Florian Krammer is a co-founder and scientific advisory board member of CastleVax. Florian Krammer has consulted for Merck, CureVac, Seqirus, GSK and Pfizer and is currently consulting for 3rd Rock Ventures, Gritstone and Avimex. The Krammer laboratory is collaborating with Dynavax on influenza vaccine development. Aubree Gordon has served on an RSV vaccine advisory board for Janssen. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10910"}}